Trademark: 86148901
Word
ALIN
Status
Dead
Status Code
710
Status Date
Friday, April 22, 2022
Serial Number
86148901
Registration Number
4824753
Registration Date
Tuesday, October 6, 2015
Mark Type
4000
Filing Date
Thursday, December 19, 2013
Published for Opposition
Tuesday, July 21, 2015
Cancellation Date
Friday, April 22, 2022

Trademark Owner History

Classifications
5 Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, endocrinology for treatment of adrenal failure, thyroiditis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely rheumatology for treatment of rheumatoid arthritis, gout, post-traumatic arthritis, osteoarthritis, synovitis, bursitis, epicondylitis, ankylosing spondylitis, systemic or discoid lupus erythematosus, dermatomyositis, scleroderma, other collagen diseases, other osteoarticular diseases which require chronic corticosteroid administration; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory; immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely dermatology for treatment of pemphigus, erythema multiforme, exfoliative dermatitis, psoriasis, contact dermatitis, keloid lesions, hyperthrophic lichen planus, alopecia areata, urticaria, eczema, rosacea; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, allergology for treatment of bronchial asthma, urticaria, drug or food allergy, hypersensitivity reactions, allergic rhinitis, allergic sinusitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely otolaryngology for treatment of vasomotor rhinitis, other types of rhinitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, ophthalmology for treatment of allergic, acute or chronic conjunctivitis; scleritis, uveitis/iridocyclitis, optic neuritis, corneal infections, keratitis, marginal ulcers, throphic disorders, conjunctival/corneal physical/chemical burning, inflammatory reactions; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, gastroenterology for treatment of ulcerative colitis, regional enteritis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, pulmonology for treatment of bronchoaspiration, Löeffler syndrome, sarcoidosis, interstitial pulmonary fibrosis, chronic bronchitis, emphysema; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely hematology for treatment of autoimmune anemias or thrombocytopenias, leukemias, lymphomas, intravascular coagulation syndrome; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, oncology for treatment of nausea/vomiting associated with cancer chemotherapy prevention; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, miscellaneous for treatment of shock syndromes, cerebral edema
The English translation of the word "ALIN" in the mark is "LOWEST".

Trademark Events
Apr 22, 2022
Cancelled Sec. 8 (6-Yr)
Oct 6, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 6, 2015
Registered-Principal Register
Jul 21, 2015
Official Gazette Publication Confirmation E-Mailed
Jul 21, 2015
Published For Opposition
Jul 1, 2015
Notification Of Notice Of Publication E-Mailed
Jun 15, 2015
1(B) Basis Deleted; New Basis Requested
Jun 15, 2015
Notice Of Allowance Cancelled
Jun 3, 2015
Attorney Review/Decision On Amendment Required
Jun 3, 2015
Petition To Director - Change Basis - Granted
Jun 2, 2015
Notice Of Approval Of Extension Request E-Mailed
Jun 1, 2015
Sou Extension 1 Granted
May 22, 2015
Sou Extension 1 Filed
May 29, 2015
Assigned To Petition Staff
May 22, 2015
Teas Extension Received
May 22, 2015
Teas Petition To Amend Basis Received
Nov 25, 2014
Noa E-Mailed - Sou Required From Applicant
Sep 30, 2014
Official Gazette Publication Confirmation E-Mailed
Sep 30, 2014
Published For Opposition
Sep 10, 2014
Notification Of Notice Of Publication E-Mailed
Aug 22, 2014
Law Office Publication Review Completed
Aug 21, 2014
Assigned To Lie
Aug 13, 2014
Approved For Pub - Principal Register
Aug 13, 2014
Examiner's Amendment Entered
Aug 13, 2014
Notification Of Examiners Amendment E-Mailed
Aug 13, 2014
Examiners Amendment E-Mailed
Aug 13, 2014
Examiners Amendment -Written
Jun 27, 2014
Assigned To Examiner
Jun 5, 2014
Teas/Email Correspondence Entered
Jun 5, 2014
Correspondence Received In Law Office
Jun 5, 2014
Teas Response To Office Action Received
Apr 1, 2014
Notification Of Non-Final Action E-Mailed
Apr 1, 2014
Non-Final Action E-Mailed
Apr 1, 2014
Non-Final Action Written
Apr 1, 2014
Notification Of Non-Final Action E-Mailed
Apr 1, 2014
Non-Final Action E-Mailed
Apr 1, 2014
Non-Final Action Written
Mar 26, 2014
Assigned To Examiner
Jan 7, 2014
New Application Office Supplied Data Entered In Tram
Dec 23, 2013
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24